Welcome to LookChem.com Sign In|Join Free
  • or
4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride, also known as DMTMM, is a white powder or chunky substance with significant applications in various fields. It is a versatile reagent and pharmaceutical intermediate, known for its ability to efficiently conjugate PnPS to Luminex microspheres without affecting the antigenicity of a broad set of PnPS.

3945-69-5

Post Buying Request

3945-69-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3945-69-5 Usage

Uses

Used in Pharmaceutical Industry:
4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride is used as a pharmaceutical intermediate for the synthesis of various drugs. It plays a crucial role in the development of new pharmaceutical compounds due to its ability to activate carboxylic acids in solution and solid phase peptide synthesis.
Used in Chemical Synthesis:
DMTMM is used as a condensing agent in chemical synthesis for several transformations, including:
Condensation of carboxylic acids and amines to form the corresponding amides in tetrahydrofuran.
Esterification of carboxylic acids with alcohols to produce the corresponding esters.
Conversion of carboxylic acids to the corresponding Weinreb amides in protic solvents.
Used in Conjugation Processes:
4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride is used as a conjugating agent that efficiently conjugates PnPS to Luminex microspheres, ensuring that the antigenicity of a broad set of PnPS remains unaffected. This application is particularly relevant in the field of immunology and diagnostic assays.

Check Digit Verification of cas no

The CAS Registry Mumber 3945-69-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,4 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3945-69:
(6*3)+(5*9)+(4*4)+(3*5)+(2*6)+(1*9)=115
115 % 10 = 5
So 3945-69-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H17N4O3.ClH/c1-14(4-6-17-7-5-14)8-11-9(15-2)13-10(12-8)16-3;/h4-7H2,1-3H3;1H/q+1;/p-1

3945-69-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D2919)  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium Chloride  >98.0%(N)

  • 3945-69-5

  • 5g

  • 480.00CNY

  • Detail
  • TCI America

  • (D2919)  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium Chloride  >98.0%(N)

  • 3945-69-5

  • 25g

  • 1,540.00CNY

  • Detail
  • Alfa Aesar

  • (H26333)  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride hydrate, 97+%   

  • 3945-69-5

  • 1g

  • 690.0CNY

  • Detail
  • Alfa Aesar

  • (H26333)  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride hydrate, 97+%   

  • 3945-69-5

  • 5g

  • 2300.0CNY

  • Detail
  • Aldrich

  • (74104)  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholiniumchloride  ≥96.0% (calc. on dry substance, AT)

  • 3945-69-5

  • 74104-1G-F

  • 828.36CNY

  • Detail
  • Aldrich

  • (74104)  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholiniumchloride  ≥96.0% (calc. on dry substance, AT)

  • 3945-69-5

  • 74104-5G-F

  • 2,769.39CNY

  • Detail

3945-69-5Synthetic route

4-methyl-morpholine
109-02-4

4-methyl-morpholine

2-chloro-4,6-dimethoxy-1 ,3,5-triazine
3140-73-6

2-chloro-4,6-dimethoxy-1 ,3,5-triazine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.5h; Alkylation;100%
In tetrahydrofuran at 20℃; for 0.5h; Substitution;100%
In tetrahydrofuran at 0℃; for 0.5h;100%
2-chloro-4,6-dimethoxy-1 ,3,5-triazine
3140-73-6

2-chloro-4,6-dimethoxy-1 ,3,5-triazine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

Conditions
ConditionsYield
With 4-methyl-morpholine In tetrahydrofuran; methanol97.4%
With 4-methyl-morpholine In tetrahydrofuran; methanol96.9%
With 4-methyl-morpholine In ethyl acetate94.6%
4-methyl-morpholine
109-02-4

4-methyl-morpholine

2-chloro-4,6-dimethoxy-1 ,3,5-triazine
3140-73-6

2-chloro-4,6-dimethoxy-1 ,3,5-triazine

A

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-morpholine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-morpholine

B

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

Conditions
ConditionsYield
In dichloromethane at 20℃; for 17h; Substitution;A 95%
B 2%
In dichloromethane at 20℃; for 0.5h; Substitution;A 21%
B 78%
4-methyl-morpholine
109-02-4

4-methyl-morpholine

2-chloro-4,6-dimethoxy-1 ,3,5-triazine
3140-73-6

2-chloro-4,6-dimethoxy-1 ,3,5-triazine

butyric acid
107-92-6

butyric acid

A

C9H13N3O4
1423116-02-2

C9H13N3O4

B

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

Conditions
ConditionsYield
In [D3]acetonitrile for 1h;
4-methyl-morpholine
109-02-4

4-methyl-morpholine

methanol
67-56-1

methanol

2-chloro-4,6-bis[3-(perfluorohexyl)propyloxy]-1,3,5-triazine

2-chloro-4,6-bis[3-(perfluorohexyl)propyloxy]-1,3,5-triazine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

Conditions
ConditionsYield
at 0 - 20℃; for 0.00416667h;
2-Methylbutanoic acid
116-53-0, 600-07-7

2-Methylbutanoic acid

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

2-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-(4,6-dimethoxy-[1,3,5]triazin-2-yl) ester

pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-(4,6-dimethoxy-[1,3,5]triazin-2-yl) ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-3-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
345911-01-5

2-tert-butoxycarbonylamino-3-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-4-methyl-pentanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
345911-00-4

2-tert-butoxycarbonylamino-4-methyl-pentanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

2-tert-butoxycarbonylamino-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
Octanoic acid
124-07-2

Octanoic acid

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

octanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

octanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
nonadecanoic acid
646-30-0

nonadecanoic acid

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

nonadecanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

nonadecanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
(E)-3-phenylacrylic acid
140-10-3

(E)-3-phenylacrylic acid

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

(E)-3-Phenyl-acrylic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
345910-94-3

(E)-3-Phenyl-acrylic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
Monomethyl phthalate
4376-18-5

Monomethyl phthalate

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

phthalic acid 1-(4,6-dimethoxy-[1,3,5]triazin-2-yl) ester 2-methyl ester

phthalic acid 1-(4,6-dimethoxy-[1,3,5]triazin-2-yl) ester 2-methyl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-3-methyl-pentanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
1026362-25-3

2-tert-butoxycarbonylamino-3-methyl-pentanoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
BOC-L-aspartic acid 4-benzyl ester
7536-58-5

BOC-L-aspartic acid 4-benzyl ester

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-succinic acid 4-benzyl ester 4-(4,6-dimethoxy-[1,3,5]triazin-2-yl) ester

2-tert-butoxycarbonylamino-succinic acid 4-benzyl ester 4-(4,6-dimethoxy-[1,3,5]triazin-2-yl) ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-3-phenyl-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
1025839-59-1

2-tert-butoxycarbonylamino-3-phenyl-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
benzoic acid
65-85-0

benzoic acid

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-(benzyloxy)-4,6-dimethoxy-1,3,5-triazin
132353-23-2

2-(benzyloxy)-4,6-dimethoxy-1,3,5-triazin

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
With 4-methyl-morpholine In water; acetone at 20℃; for 0.25h;
With 4-methyl-morpholine In 1,4-dioxane; water at 20℃; for 0.25h;
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

3-Phenylpropionic acid
501-52-0

3-Phenylpropionic acid

3-phenyl-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

3-phenyl-propionic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
With 4-methyl-morpholine In 1,4-dioxane; water at 20℃; for 0.25h;
C25H23NO6

C25H23NO6

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

C30H28N4O8
718627-81-7

C30H28N4O8

Conditions
ConditionsYield
In chloroform at 0 - 5℃; for 12h;100%
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-morpholine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-morpholine

Conditions
ConditionsYield
In dichloromethane at 20℃; for 3h; demethylation;96%
In dichloromethane at 20℃; for 3h; Decomposition;96%
In dichloromethane at 20℃; for 3h;96%
In ethyl acetate at 23 - 29℃; for 0.5h; Conversion of starting material;
2-(tert-butoxycarbonylamino)-3-phenylpropionic acid
4530-18-1

2-(tert-butoxycarbonylamino)-3-phenylpropionic acid

methyl (2S)-2-amino-3-phenylpropanoate
2577-90-4

methyl (2S)-2-amino-3-phenylpropanoate

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

(S)-methyl 2-((S)-2-(tert-butoxycarbonylamino)-3-phenylpropanamido)-3-phenylpropanoate
13122-89-9

(S)-methyl 2-((S)-2-(tert-butoxycarbonylamino)-3-phenylpropanamido)-3-phenylpropanoate

Conditions
ConditionsYield
In dichloromethane; water95%
(2S)-2-[(2S)-2-[[(tert-butoxy)carbonyl](methyl)amino]propanamido]-2-cyclohexylacetic acid
894789-27-6

(2S)-2-[(2S)-2-[[(tert-butoxy)carbonyl](methyl)amino]propanamido]-2-cyclohexylacetic acid

C16H18FN3

C16H18FN3

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

A

C21H23FN6O2

C21H23FN6O2

B

C33H46FN5O4

C33H46FN5O4

C

C33H46FN5O4

C33H46FN5O4

Conditions
ConditionsYield
In ethyl acetate at -20 - 20℃;A n/a
B n/a
C 95%
N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

(S)-2-tert-butoxycarbonylamino-3-phenyl-propionic acid methyl ester
51987-73-6

(S)-2-tert-butoxycarbonylamino-3-phenyl-propionic acid methyl ester

Conditions
ConditionsYield
With 4-methyl-morpholine; hydrogenchloride; sodium hydroxide In methanol; diethyl ether; water93%
With 4-methyl-morpholine; hydrogenchloride In methanol; dichloromethane; water
2-azido-3,4,6-tri-O-benzyl-2-deoxy-D-glucopyranose

2-azido-3,4,6-tri-O-benzyl-2-deoxy-D-glucopyranose

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

4,6-dimethoxy-1,3,5-triazine-2-yl-2-azido-3,4,6-tri-O-benzyl-2-deoxy-D-glucopyranoside

4,6-dimethoxy-1,3,5-triazine-2-yl-2-azido-3,4,6-tri-O-benzyl-2-deoxy-D-glucopyranoside

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 0 - 20℃; for 8h; Inert atmosphere;93%
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

4-nitro-benzoic acid
62-23-7

4-nitro-benzoic acid

4-Nitro-benzoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
132353-24-3

4-Nitro-benzoic acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In dichloromethane at 0 - 20℃;92%
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

triethylammonium (SP)-5'-O-DMT-thymidine-3'-O-methylphosphonothioate

triethylammonium (SP)-5'-O-DMT-thymidine-3'-O-methylphosphonothioate

(RP)-5'-O-DMT-thymidine-3'-O-((4,6-dimethoxy-1,3,5-triazin-2-yl)methylphosphonothioate)
959156-15-1

(RP)-5'-O-DMT-thymidine-3'-O-((4,6-dimethoxy-1,3,5-triazin-2-yl)methylphosphonothioate)

Conditions
ConditionsYield
In acetonitrile at 20℃;90%
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

triethylammonium (RP)-5'-O-DMT-thymidine-3'-O-methylphosphonothioate

triethylammonium (RP)-5'-O-DMT-thymidine-3'-O-methylphosphonothioate

(SP)-5'-O-DMT-thymidine-3'-O-((4,6-dimethoxy-1,3,5-triazin-2-yl)methylphosphonothioate)
959156-14-0

(SP)-5'-O-DMT-thymidine-3'-O-((4,6-dimethoxy-1,3,5-triazin-2-yl)methylphosphonothioate)

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;88%
4,5-dihydro-1H-pyrrole-1,5-dicarboxylic acid 1-(1,1-dimethylethyl) sodium salt

4,5-dihydro-1H-pyrrole-1,5-dicarboxylic acid 1-(1,1-dimethylethyl) sodium salt

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

A

(5S)-5-aminocarbonyl-4,5-dihydro-1H-pyrrole-1-carboxylic acid 1-(1,1-dimethylethyl) ester
709031-38-9

(5S)-5-aminocarbonyl-4,5-dihydro-1H-pyrrole-1-carboxylic acid 1-(1,1-dimethylethyl) ester

B

4, 6-DIMEO-1, 3,5-triazene ether (DMT-ether)

4, 6-DIMEO-1, 3,5-triazene ether (DMT-ether)

Conditions
ConditionsYield
With sodium hydroxide; sodium dihydrogenphosphate; ammonium chloride at 20℃; for 4h; pH=6.20; Conversion of starting material;A 87%
B 12%
C32H34N2O9P(1-)

C32H34N2O9P(1-)

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

A

C37H40N5O11P

C37H40N5O11P

B

C64H68N4O17P2

C64H68N4O17P2

Conditions
ConditionsYield
In acetonitrile at 20℃;A 5%
B 85%
N-acetyl-D-glucosamine
10036-64-3

N-acetyl-D-glucosamine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

4,6-dimethoxy-1,3,5-triazin-2-yl α-N-acetylglucosaminide
1337923-38-2

4,6-dimethoxy-1,3,5-triazin-2-yl α-N-acetylglucosaminide

Conditions
ConditionsYield
With 2,6-dimethylpyridine In water at 20℃; for 24h; regioselective reaction;84%
(2S)-2-[(2S)-2-[[(tert-butoxy)carbonyl](methyl)amino]propanamido]-2-cyclohexylacetic acid
894789-27-6

(2S)-2-[(2S)-2-[[(tert-butoxy)carbonyl](methyl)amino]propanamido]-2-cyclohexylacetic acid

3-(4-fluoro-phenoxy)-5-(S)-pyrrolidin-2-yl-pyridine
1005342-91-5

3-(4-fluoro-phenoxy)-5-(S)-pyrrolidin-2-yl-pyridine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

A

C20H20FN5O3

C20H20FN5O3

B

C32H43FN4O5

C32H43FN4O5

C

C32H43FN4O5
1005342-92-6

C32H43FN4O5

Conditions
ConditionsYield
In ethyl acetate at -20 - 20℃;A n/a
B n/a
C 82%

3945-69-5Relevant academic research and scientific papers

4-(4,6-dimethoxy[1,3,5]triazin-2-yl)-4-methyl-morpholinium chloride (DMTMM): A valuable alternative to PyBOP for solid phase peptide synthesis

Falchi, Alessandro,Giacomelli, Giampaolo,Porcheddu, Andrea,Taddei, Maurizio

, p. 275 - 277 (2000)

The salt formed from 2-chloro-4,6-dimethoxy[1,3,5]triazine and N- methylmorpholine (DMTMM) is an effective coupling agent for solid phase peptide synthesis that can be used as economical alternative to PyBOP. Several oligopeptides were prepared on a Wang type resin using this reagent and the yields and purity of the products were always comparable with those obtained with PyBOP as the coupling agent.

Synthesis and Properties of Functional Glycomimetics through Click Grafting of Fucose onto Chondroitin Sulfates

Fan, Fei,Zhang, Ping,Wang, Lihao,Sun, Tiantian,Cai, Chao,Yu, Guangli

, (2019)

Fucosylated chondroitin sulfate (fCS), a representative marine polysaccharide isolated from sea cucumber, possesses diverse biological functions especially as a promising anticoagulant. However, its supply suffers from the challenges of high-cost materials, different species, and batch-to-batch variability. In the present study, we designed a concise route for the synthesis of functional glycomimetics by natural fCS as a template. 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride-mediated amidation was applied on chondroitin sulfates for site-selective alkynylation with controllable ratios between 0.15 and 0.78. A small library of 12 fCS glycomimetics with specific sulfation patterns and fucose branches was prepared through copper-catalyzed azide-alkyne cycloaddition, which was fully characterized by nuclear magnetic resonance spectroscopy and size-exclusion chromatography with multiangle light scattering and refractive index. Through screening of their biological activities, CSE-F1 and CSE-SF1 exhibited anticoagulant activities through intrinsic pathway and inhibition of factor Xa by antithrombin III. The concise approach developed herein supplies novel glycopolymers to mimic the distinct functions of natural polysaccharides and promote the development of marine carbohydrate-based drugs.

Kinetically driven intra-and interchain association of hydrophobically and hydrophilically modified poly(acrylic acid) in dilute aqueous solutions

Hao, Jinkun,Li, Zhiyong,Cheng, He,Wu, Chi,Han, Charles C.

, p. 9534 - 9540 (2010)

Effects of pH, dodecyl, and PEO contents as well as the method of preparing the solution on the formation of the unimolecular micelles (unimer micelle) or aggregates made of poly(acrylic acid)-graftpoly( ethylene oxide)-graft-dodecyl (PAA-g-PEO-g-dodecyl) and PAA-g-dodecyl have been studied by a combination of static and dynamic laser light scattering (SLS and DLS). It revealed that: in most cases, these copolymers tend to form interchain associates; while low pH value, proper high dodecyl content and fast switch rate of solvent quality promote intrachain association. These phenomena of the system being trapped in a metastable state can be mainly attributed to its kinetic pathway: the factors mentioned earlier can enhance the initial intrachain contraction, leading to τc (interaction time) e (entanglement time) for the two interaction intrachain globules. So they behave like tiny "elastic balls" and their further merge/fusion become nearly impossible during their interaction time (τc). In this way, the copolymer system is trapped in the metastable, unimer micelle state. The interplay of τc and τe in the formation of metastable unimer micelles or stable aggregates has been discussed in detail.

Bifunctional copper(II) chelators from the coupling of the encapsulating ligand 1-methyl-8-amino-3,13,16-trithia-6,10,19-triazabicyclo[6.6.6]icosane (AMN3S3sar) with carboxylic acids; Applications of the coupling agent DMT-MM

Lee, Hui Hui,Lim, Peiying Alinia,Vu, Hoan,Poulsen, Sally-Ann,Gahan, Lawrence R.

, p. 627 - 634 (2015)

Reaction of 1-methyl-8-amino-3,13,16-trithia-6,10,19-triazabicyclo[6.6.6]icosane (AMN3S3sar) with the amide coupling agent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM) and 4-nitrobenzoic acid, the protected amine 4-(1,3-dioxoisoindolin-2-yl)benzoic acid and the tricarboxylic acid, benzene-1,3,5-tricarboxylic acid (trimesic acid) resulted in the three new ligands N3S3amideSarArNO2, N3S3amideSarAr, and (AMN3S3sar)3TMA. Two of the respective copper(II) complexes have been isolated and characterized.

Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts

Morandini, Andrea,Leonetti, Benedetta,Riello, Pietro,Sole, Roberto,Gatto, Vanessa,Caligiuri, Isabella,Rizzolio, Flavio,Beghetto, Valentina

supporting information, p. 3172 - 3176 (2021/08/03)

Efficient, environmentally and economically sustainable, and nontoxic antibacterial products are of global relevance in the fight against microorganism contamination. In this work, an easy and straightforward method for the synthesis of bis-morpholino triazine quaternary ammonium salts (bis-mTQAS) is reported, starting from 2,4,6-trichloro-1,3,5-triazine or 2,4-dichloro-6-methoxy-1,3,5-triazine and various N-alkylmorpholines. Bis-mTQAS were tested as antimicrobials against Gram-negative and Gram-positive bacterial strains. The best-performing bis-mTQAS were found to achieve total disinfection against Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922 at 50 and 400 μg/mL, respectively. Distinctively, bis-mTQAS with the highest antimicrobial efficiency had lowest cytotoxicity.

Phosphorus-Based Organocatalysis for the Dehydrative Cyclization of N-(2-Hydroxyethyl)amides into 2-Oxazolines

Foo, Siong Wan,Mori, Shogo,Ogawa, Saeko,Saito, Susumu,Soleymani Movahed, Farzaneh

, (2021/12/17)

A metal-free, biomimetic catalytic protocol for the cyclization of N-(2-hydroxyethyl)amides to the corresponding 2-oxazolines (4,5-dihydrooxazoles), promoted by the 1,3,5,2,4,6-triazatriphosphorine (TAP)-derived organocatalyst tris(o-phenylenedioxy)cyclotriphosphazene (TAP-1) has been developed. This approach requires less precatalyst compared to the reported relevant systems, with respect to the phosphorus atom (the maximum turnover number (TON) ~30), and exhibits a broader substrate scope and higher functional-group tolerance, providing the functionalized 2-oxazolines with retention of the configuration at the C(4) stereogenic center of the 2-oxazolines. Widely accessible β-amino alcohols can be used in this approach, and the cyclization of N-(2-hydroxyethyl)amides provides the desired 2-oxazolines in up to 99% yield. The mechanism of the reaction was studied by monitoring the reaction using spectral and analytical methods, whereby an 18O-labeling experiment furnished valuable insights. The initial step involves a stoichiometric reaction between the substrate and TAP-1, which leads to the in situ generation of the catalyst, a catechol cyclic phosphate, as well as to a pyrocatechol phosphate and two possible active intermediates. The dehydrative cyclization was also successfully conducted on the gram scale.

Site-Selective Modification of Peptides and Proteins via Interception of Free-Radical-Mediated Dechalcogenation

Griffiths, Rhys C.,Smith, Frances R.,Long, Jed E.,Williams, Huw E. L.,Layfield, Robert,Mitchell, Nicholas J.

supporting information, p. 23659 - 23667 (2020/10/21)

The development of site-selective chemistry targeting the canonical amino acids enables the controlled installation of desired functionalities into native peptides and proteins. Such techniques facilitate the development of polypeptide conjugates to advance therapeutics, diagnostics, and fundamental science. We report a versatile and selective method to functionalize peptides and proteins through free-radical-mediated dechalcogenation. By exploiting phosphine-induced homolysis of the C?Se and C?S bonds of selenocysteine and cysteine, respectively, we demonstrate the site-selective installation of groups appended to a persistent radical trap. The reaction is rapid, operationally simple, and chemoselective. The resulting aminooxy linker is stable under a variety of conditions and selectively cleavable in the presence of a low-oxidation-state transition metal. We have explored the full scope of this reaction using complex peptide systems and a recombinantly expressed protein.

POLYPEPT(O)ID-BASED GRAFT COPOLYMERS FOR IN VIVO IMAGING BY TETRAZINE TRANSCYCLOOCTENE CLICK CHEMISTRY

-

Page/Page column 11, (2020/01/24)

There is provided novel polypeptide-based carrier systems, which make it possible to label polymeric nanoparticles in the living organism. This enables new approaches in tumor diagnostics (high signal to background ratio) and radiotherapy (radiotherapy of solid tumors). The polypeptide-based carrier system comprises a polypept(o)idic comb (graft) copolymer, and one or more tetrazine bioorthogonal functional groups each linked to a diagnostic agent.

Heparin alendronate sodium conjugate synthetic method and drugs

-

Paragraph 0009; 0030-0032, (2019/10/01)

The invention relates to a heparin alendronate sodium conjugate synthetic method and drugs in the field of medicine. The heparin alendronate sodium conjugate synthetic method comprises the steps: step1, firstly, dissolving 2-chloro-4,6-dimethoxy-1,3,5-triazine in tetrahydrofuran, adding 4-methylmorpholine, stirring for 1-2 h at room temperature, collecting by filtration and washing a precipitatefive times with THF, and thus then obtaining a DMT-MM condensation agent after 48 h of vacuum drying; and step 2, adding heparin and the condensation agent into ultra-pure water, stirring for 1 h, then adding an alendronate sodium solution into the mixed solution of heparin and the condensation agent, carrying out reaction for 24-48 h, pouring the solution into a dialysis bag, dialysing for 48-72h, changing water once every 4 h, finally, freeze-drying the product obtained from dialysis, and thus obtaining the heparin alendronate sodium conjugate drugs. In the method, alendronate sodium is modified by heparin, so the solubility of the drugs is increased, the bioavailability is improved, the cytotoxicity is reduced and the formation of osteoclasts is effectively inhibited.

Indole and quinoline derivatives and its preparation method and application

-

Paragraph 0112; 0114, (2017/02/28)

The invention provides an indoloquinoline derivative, a preparation method and application thereof in preparing antitumor drugs and antiviral drugs. The chemical structure of the indoloquinoline derivative is shown as a formula I. Experiments show that a partly-boric-acid-modified indoloquinoline derivative and a non-boric-acid-modified indoloquinoline derivative have strong inhibition effect on various tumor cell strains, thereby being capable of being used for preparation of the antitumor drugs, and have strong antiviral activity, thereby being capable of being used for preparation of the antiviral drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3945-69-5